Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Aspurūs Shatavari Supports Menopause Symptoms Within Two Weeks: Study   - Nutraceuticals World

What are you searching for?

Sign in
Research

Aspurūs Shatavari Supports Menopause Symptoms Within Two Weeks: Study  

The study found significant improvements in self-reported symptoms related to hot flashes, sexual health, and physiological well-being.

Author Image

By: Mike Montemarano

Associate Editor, Nutraceuticals World

Photo: wasanajai | Adobe Stock

Aspurūs, a seven-bioactive standardized shatavari extract supplied by Waleria, was shown in a recent clinical study of 150 perimenopausal women to support vasomotor, psychological, cognitive, and physical symptoms of menopause as early as two weeks. The findings of the 12-week, randomized, double-blind, placebo-controlled study were published in The Journal of Dietary Supplements.

While most perimenopause studies focus on the frequency of symptom improvement, such as the number of hot flashes, this study design also took symptom intensity into account using a validated questionnaire to provide a more complete picture.

Other validated scales were used to yield data on hot flashes, sexual health, and physical stamina. Symptoms like brain fog, fatigue, stress, joint pain, and more were assessed, providing broad clinical insights compared to most perimenopause studies.

Compared to placebo, women receiving Aspurūs experienced significant improvements across several perimenopausal symptoms during the 12-week intervention. Improvements were observed in hot flashes (-76.7%) and fatigue (-74.6%), along with brain fog (-44.9%), stress (-51.7%), mood (-51.1%), sexual health (-60%), sleep (-45.1%) and overall quality of life (-51.1%) assessment scores. The extract was well tolerated throughout the study, with no serious adverse events reported.

“Perimenopause is a highly individual experience, and women rarely experience the same journey,” said Komal Baldwa, founder of Waleria Healthtech. “We elevated the study design to evaluate both the frequency and intensity of symptoms across multiple domains, reflecting the experience of modern perimenopausal women.”

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics